PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4124

  1. 125 Posts.
    lightbulb Created with Sketch. 10
    @@jcurve Perhaps PAR should consider transitioning into a veterinary science company, given that both of their "new" patents pertain to animals
    Last edited by m931392: 05/06/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.